| Pharmaceutical active ingredients: |
| Estradiol HemihydrateNorethindrone Acetate |
| Available forms, composition and doses of Evorel Presentacion Dual Secuencial: |
| 4 Evorel Patches; Topical; Estradiol Hemihydrate 1.6 mg / 4 Evorel Conti Patches; Topical; Estradiol Hemihydrate 3.2 mg; Norethindrone Acetate 11.2 mg4 Evorel Patches; Topical; Estradiol Hemihydrate 3.2 mg / 4 Evorel Conti Patches; Topical; Estradiol Hemihydrate 3.2 mg; Norethindrone Acetate 11.2 mg4 Evorel Patches; Topical; Estradiol Hemihydrate 6.4 mg / 4 Evorel Conti Patches; Topical; Estradiol Hemihydrate 3.2 mg; Norethindrone Acetate 11.2 mg |
| Evorel Presentacion Dual Secuencial medical category: |
| Human:EstrogensProgestins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03CA53 - Estradiol, combinationsG03FA01 - Norethisterone and estrogen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Janssen |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Estranor | Estradiol Hemihydrate; Norethindrone Acetate | Sandoz |
| Estranor Eco | Estradiol Hemihydrate; Norethindrone Acetate | Sandoz |
| Evorel Conti | Estradiol Hemihydrate; Norethindrone Acetate | Janssen |
| Evorel Micronor | Estradiol Hemihydrate; Norethindrone Acetate | Janssen |
| Evorel Pak | Estradiol Hemihydrate; Norethindrone Acetate | Janssen |
| Evorel Sequi | Estradiol Hemihydrate; Norethindrone Acetate | Janssen |
| Evorel; EvorelConti | Estradiol Hemihydrate; Norethindrone Acetate | Janssen |
| EvorelConti | Estradiol Hemihydrate; Norethindrone Acetate | Janssen |
| Evo-Sequi | Estradiol Hemihydrate; Norethindrone Acetate | Janssen |
| Kliane | Estradiol Hemihydrate; Norethindrone Acetate | Bayer Schering Pharma |